Showing results (251-260 of 369) with videos related to

Sort By:
Pageof 37
European Journal of Haematology|October 1, 1994
In vitro improvement of bone marrow-derived hematopoietic colony formation in HIV-positive patients by alpha-D-tocopherol and erythropoietinR G Geissler, A Ganser, O G Ottmann, et al.
British Journal of Cancer|July 14, 1998
Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanomaA Franzke, M Probst-Kepper, J Buer, et al.
Bone Marrow Transplantation|June 29, 2000
Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcomeC Duncker, D Dohr, S Harsdorf, et al.
Leukemia|November 1, 1993
Restoration of impaired cytokine secretion from monocytes of patients with myelodysplastic syndromes after in vivo treatment with GM-CSF or IL-3A B Maurer, A Ganser, R Buhl, et al.
Lupus Science & Medicine|November 8, 2014
Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodiesWendy Marder, Vivian C Romero, Martha A Ganser, et al.
Environmental Health Perspectives|February 10, 2015
Mercury Exposure and Antinuclear Antibodies among Females of Reproductive Age in the United States: NHANESEmily C Somers, Martha A Ganser, Jeffrey S Warren, et al.
British Journal of Haematology|May 8, 1999
Endogenous serum levels of thrombopoietic cytokines in healthy whole-blood and platelet donors: implications for plateletpheresisF Tacke, P Schöffski, C Trautwein, et al.
British Journal of Cancer|January 1, 1997
Elevated serum levels of S100 and survival in metastatic malignant melanomaJ Buer, M Probst, A Franzke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 16, 2001
Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNAM Scherr, J LeBon, D Castanotto, et al.
Leukemia|February 8, 2019
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidineR F Schlenk, D Weber, W Herr, et al.
Pageof 37